Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | CCR6 | P51684 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MPL | P40238 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7252767 | 0.76 | ALDH1A1 (0.59) | HCAR1ALDH1A1KMT2AHTTHSD17B10 | |
| SCHEMBL11094674 | 0.72 | ALDH1A1 (0.57) | ALDH1A1KMT2AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL5378943 | 0.70 | KMT2A (0.46) | HCAR1ALDH1A1KMT2AHTTHSD17B10 | |
| SCHEMBL9040846 | 0.70 | MAPT (0.41) | HCAR1ALDH1A1KMT2ALMNAMAPK1 | |
| SCHEMBL4071522 | 0.70 | SMN1; SMN2 (0.49) | HCAR1ALDH1A1KMT2AHTTHSD17B10 | |
| SCHEMBL11862671 | 0.68 | HCAR1 (0.47) | HCAR1ALDH1A1KMT2AHTTHSD17B10 | |
| SCHEMBL710745 | 0.68 | TLR9 (0.59) | ALDH1A1KMT2AHTTHSD17B10LMNA | |
| SCHEMBL29510755 | 0.68 | TLR9 (0.59) | ALDH1A1KMT2AHTTHSD17B10LMNA | |
| SCHEMBL1274938 | 0.67 | HTT (0.73) | ALDH1A1KMT2AHTTLMNAMAPK1 | |
| SCHEMBL1320968 | 0.67 | GRIK1 (0.49) | HCAR1ALDH1A1KMT2AHTTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2038263-B1 | NOVEL AROMATIC AZA HETEROCYCLES, METHOD OF PRODUCTION AND USE OF THE MATERIAL IN ORGANIC ELECTRONICS | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2014-03-05 | — | — | EP | disclosed |
| US-8232393-B2 | Aromatic AZA heterocycles, method of production and use of the material in organic electronics | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2012-07-31 | — | — | US | disclosed |
| US-20090318691-A1 | Novel Aromatic AZA Heterocycles, Method of Production and Use of the Material in Organic Electronics | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2009-12-24 | — | — | US | disclosed |
| EP-0521019-A1 | PYRAZOLO 1,5-a]BENZIMIDAZOLE PHOTOGRAPHIC COLOUR COUPLERS | KODAK LIMITED (GB) | 1993-01-07 | — | — | EP | disclosed |
| WO-1991014970-A1 | PYRAZOLO[1,5-a]BENZIMIDAZOLE PHOTOGRAPHIC COLOUR COUPLERS | KODAK LIMITED (GB) | 1991-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318691-A1 | Novel Aromatic AZA Heterocycles, Method of Production and Use of the Material in Organic Electronics | SLC25A21, AOC2, SLC19A1 | HCAR1 3533/4885ALDH1A1 728/4885KMT2A 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.